News & Events

Company & Partner News

Apr 13, 2022

2022 Letter to Stockholders

View Press Release Learn More

FDA approves Roche’s novel bispecific antibody for treatment of nAMD and DME

2021 Year-end Letter to Shareholders

XOMA Purchases Commercial Payment Rights to BLA-Review-Stage Asset

Latest News

Aug 4, 2022 • 7:30 AM EDT

XOMA Reports Second Quarter 2022 Financial Results and Highlights Recent Operational Events

Jun 20, 2022 • 7:30 AM EDT

XOMA Declares Quarterly Preferred Stock Dividends

May 17, 2022 • 4:05 PM EDT

XOMA to Present at H.C. Wainwright Global Investment Conference

View All Press Releases

Corporate Presentation

View Presentation